Watch HNGE. Know when insiders buy.
One email the day a filing lands. Free.
Work order
45
WATCH · insiders 25, shorts 65
Insiders, 90 days
−$3M
net selling · 0 buys, 5 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E 30.6DIV YIELD —FCF YIELD —REV TTM $720.1M +49.8%NET INCOME $109.1MNET CASH —52W 31.17 – 92.85NEXT EARNINGS Nov 3 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $212.8M | +53.0% | 86.4% | $40.4M | $43.7M | — | 0.52 | $101.4M | $123K | $101.3M | Aug 6 |
| Q1 2026 · Mar 31 | $182.3M | +47.2% | 84.6% | $32.1M | $35.1M | +105.0% | 0.41 | $43.1M | $83K | $43M | May 7 |
| Q4 2025 · Dec 31derived | $170.7M | +45.6% | 84.4% | $27.3M | $32.1M | +18.4% | 2.11 | $63.9M | $408K | $63.5M | Mar 3 |
| Q3 2025 · Sep 30 | $154.2M | +53.3% | 81.8% | −$6.1M | −$1.8M | −640.8% | -0.02 | $82.4M | $52K | $82.3M | Nov 7 |
| Q2 2025 · Jun 30 | $139.1M | +54.9% | 70.3% | −$580.7M | −$575.7M | — | -13.10 | $20.2M | $197K | $20M | Aug 6 |
| Q1 2025 · Mar 31 | $123.8M | — | 80.9% | $13.1M | $17.1M | — | 1.31 | $4.9M | $51K | $4.9M | May 7 |
| Q4 2024 · Dec 31derived | $117.3M | — | 81.9% | $20.9M | $27.1M | — | 2.01 | $38.3M | $157K | $38.2M | Mar 3 |
| Q3 2024 · Sep 30 | $100.6M | — | 78.8% | −$3.8M | $341K | — | 0.01 | $28.4M | $315K | $28.1M | Nov 7 |
| Q2 2024 · Jun 30 | $89.8M | — | 74.2% | −$17.6M | −$12.9M | — | -0.96 | — | — | — | Nov 7 |
| Q1 2024 · Mar 31 | — | — | — | — | −$26.5M | — | — | — | — | — | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $587.9M | 79.6% | −$546.4M | −$528.3M | -89.9% | -7.77 | $171.4M | $708K | $170.7M | $65M | — |
| FY2024 · to Dec 31 | $390.4M | 76.8% | −$31.9M | −$11.9M | -3.1% | -0.88 | $49M | $1M | $48M | $0 | — |
| FY2023 · to Dec 31 | $292.7M | 66.3% | −$130.5M | −$108.1M | -36.9% | -8.31 | −$63.9M | $2M | −$65.9M | $0 | — |
Every number comes from Hinge Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.